Table VI

Summary of Sites by Stage, Race, and Sex
Indiana, 1998

Site	Number* of Cases	Percent of Total Cases	SEER** Summary Stage at Diagnosis					Race			Sex
Site	Number* of Cases	Percent of Total Cases	In Situ	Local	Regional	Distant	Unstaged	White	African-American	Other	Male	Female
All sites	28,548	100.0%	2,577	11,664	6,619	5,637	2,051	26,444	1,953	119	13,381	15,167
Oral cavity and pharynx	645	2.3%	18	258	294	46	29	587	53	4	449	196
Lip	78	0.3%	3	69	2	0	4	77	1	0	67	11
Tongue	135	0.5%	4	45	69	9	8	119	15	1	98	37
Major salivary glands	63	0.2%	1	36	21	4	1	59	3	1	32	31
Floor of mouth	51	0.2%	4	17	26	2	2	47	4	0	36	15
Gum and other mouth	105	0.4%	3	50	41	6	5	94	9	1	55	50
Nasopharynx	30	0.1%	0	2	20	6	2	26	3	1	22	8
Tonsil	85	0.3%	1	17	59	7	1	78	7	0	63	22
Oropharynx	20	0.1%	0	8	10	1	1	15	5	0	14	6
Hypopharynx	56	0.2%	1	13	35	6	1	51	5	0	44	12
Pharynx and other oral cavity	22	0.1%	1	1	11	5	4	21	1	0	18	4
Digestive system	5,464	19.1%	283	1,484	2,166	1,145	386	5,051	382	27	2,809	2,655
Esophagus	283	1.0%	7	66	103	67	40	253	27	2	217	66
Stomach	353	1.2%	3	65	134	113	38	310	41	2	231	122
Small intestine	90	0.3%	0	23	29	33	5	79	11	0	47	43
Colon excluding rectum	2,661	9.3%	186	775	1,157	450	93	2,473	181	7	1,207	1,454
Rectum and rectosigmoid	1,038	3.6%	76	351	396	152	63	991	40	6	593	445
Anus, anal canal, and anorectum	76	0.3%	8	34	25	1	8	70	6	0	23	53
Liver and intrahepatic bile duct	215	0.8%	0	74	41	50	50	190	17	7	151	64
Gallbladder	71	0.2%	2	21	27	19	2	65	5	1	17	54
Other biliary	74	0.3%	1	17	27	12	17	66	6	2	41	33
Pancreas	531	1.9%	0	46	212	213	60	487	43	0	261	270
Retroperitoneum	27	0.1%	0	9	11	4	3	26	1	0	12	15
Peritoneum	35	0.1%	0	2	3	25	5	32	3	0	2	33
Other digestive organs	10	0.0%	0	1	1	6	2	9	1	0	7	3
Respiratory system	5,045	17.7%	34	1,207	1,415	2,030	359	4,640	394	10	3,068	1,977
Nasal cavity, ear, and sinuses	43	0.2%	1	13	21	5	3	40	3	0	30	13
Larynx	318	1.1%	18	172	110	9	9	286	32	0	250	68
Lung and bronchus	4,621	16.2%	15	999	1,268	2,007	332	4,255	355	10	2,737	1,884
Trachea, pleura, and other respiratory organs	63	0.2%	0	23	16	9	15	59	4	0	51	12
Bones and joints	62	0.2%	0	31	17	11	3	55	7	0	36	26
Soft tissue (including heart)	171	0.6%	0	96	32	21	22	157	14	0	94	77
Skin (excluding basal and squamous)	971	3.4%	174	642	67	36	52	952	14	1	550	421
Melanoma of the skin	890	3.1%	174	585	64	26	41	881	4	1	509	381
Other non-epithelial skin cancers	81	0.3%	0	57	3	10	11	71	10	0	41	40
Breast	4,882	17.1%	712	2,678	1,218	194	80	4,543	316	19	34	4,848
Female genital system	2,495	8.7%	804	960	333	333	65	2,318	154	18	0	2,495
Cervix uteri	965	3.4%	661	166	104	21	13	877	73	11	0	965
Corpus uteri	781	2.7%	14	569	116	61	21	732	43	5	0	781
Uterus, NOS	7	0.0%	0	3	0	2	2	6	1	0	0	7
Ovary	486	1.7%	0	149	81	237	19	456	28	2	0	486
Vagina	36	0.1%	8	13	7	5	3	36	0	0	0	36
Vulva	207	0.7%	121	55	23	3	5	198	9	0	0	207
Other female genital organs	13	0.0%	0	5	2	4	2	13	0	0	0	13
Male genital system	3,242	11.4%	18	2,421	369	225	209	2,927	294	14	3,242	0
Prostate gland	3,026	10.6%	9	2,273	329	209	206	2,721	288	11	3,026	0
Testis	179	0.6%	0	128	33	15	3	173	3	3	179	0
Penis	32	0.1%	9	18	5	0	0	29	2	0	32	0
Other male genital organs	5	0.0%	0	2	2	1	0	4	1	0	5	0
Urinary system	2,098	7.3%	532	989	276	223	78	1,982	102	11	1,409	689
Urinary bladder	1,278	4.5%	507	551	125	49	46	1,225	42	8	929	349
Kidney and renal pelvis	758	2.7%	12	407	141	170	28	696	59	3	447	311
Ureter	45	0.2%	9	23	9	1	3	45	0	0	22	23
Other urinary organs	17	0.1%	4	8	1	3	1	16	1	0	11	6
Eye and orbit	50	0.2%	1	36	6	2	5	47	3	0	27	23
Brain and other nervous system	363	1.3%	0	268	48	6	41	348	14	1	199	164
Brain	341	1.2%	0	257	45	3	36	328	12	1	193	148
Other nervous system	22	0.1%	0	11	3	3	5	20	2	0	6	16
Endocrine system	380	1.3%	1	244	92	30	13	348	28	4	89	291
Thyroid gland	342	1.2%	1	228	87	18	8	318	20	4	70	272
Other endocrine (including thymus)	38	0.1%	0	16	5	12	5	30	8	0	19	19
Lymphoma	1,228	4.3%	0	342	286	465	135	1,157	65	4	623	605
Hodgkin's disease	182	0.6%	0	46	69	59	8	165	16	1	102	80
Non-Hodgkin's lymphoma	1,046	3.7%	0	296	217	406	127	992	49	3	521	525
Multiple myeloma	265	0.9%	0	6	0	255	4	222	42	1	139	126
Leukemia	603	2.1%	0	0	0	600	3	557	42	4	338	265
Acute lymphocytic	72	0.3%	0	0	0	72	0	67	5	0	42	30
Chronic lymphocytic	166	0.6%	0	0	0	166	0	156	9	1	104	62
Acute myeloid	142	0.5%	0	0	0	141	1	134	7	1	61	81
Chronic myeloid	97	0.3%	0	0	0	97	0	85	11	1	60	37
Other leukemias	126	0.4%	0	0	0	124	2	115	10	1	71	55
Other, ill-defined and unknown sites	584	2.0%	0	2	0	15	567	553	29	1	275	309
* Please note that these totals will not match those in Table VII - 0 as these numbers include all in situ cases, though basal and squamous skin cell cancers are still excluded. ** Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. Source : Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, February 2003

Table of Contents

Table VI

Summary of Sites by Stage, Race, and SexIndiana, 1998

Summary of Sites by Stage, Race, and Sex
Indiana, 1998